| 注册
首页|期刊导航|Oncology Research|The SS18-SSX fusion oncoprotein:Friend and foe in targeted therapy for synovial sarcoma

The SS18-SSX fusion oncoprotein:Friend and foe in targeted therapy for synovial sarcoma

GAVIN M.ANCHONDO KYRA PARKER ALEXIS BRUCE ELIZABETH CORTEZ LE SU

Oncology Research2025,Vol.33Issue(5):P.1001-1005,5.
Oncology Research2025,Vol.33Issue(5):P.1001-1005,5.DOI:10.32604/or.2025.060573

The SS18-SSX fusion oncoprotein:Friend and foe in targeted therapy for synovial sarcoma

GAVIN M.ANCHONDO 1KYRA PARKER 1ALEXIS BRUCE 1ELIZABETH CORTEZ 1LE SU1

作者信息

  • 1. Department of Biology,Jacksonville State University,Jacksonville,AL 36265,USA
  • 折叠

摘要

关键词

SS18-SSX/Synovial sarcoma/Targeted therapy

分类

医药卫生

引用本文复制引用

GAVIN M.ANCHONDO,KYRA PARKER,ALEXIS BRUCE,ELIZABETH CORTEZ,LE SU..The SS18-SSX fusion oncoprotein:Friend and foe in targeted therapy for synovial sarcoma[J].Oncology Research,2025,33(5):P.1001-1005,5.

Oncology Research

0965-0407

访问量0
|
下载量0
段落导航相关论文